gnipst bulletin 29.3

7/27/2019 Gnipst Bulletin 29.3

1/17

1

1118-1177-4796-9849-7562-5062mail

GGGNNNIIIPPPSSSTTTBBBUUULLLLLLEEETTTIIINNN 222000111333

4th

October , 2013 Volume No.: 29 Issue No.: 03

Contents Message from GNIPS

Letter to the Editor News Update

Health awareness

Disease Outbreak Ne

Forth Coming Events

Drugs Update

Campus News

Students Section

Editors Note

Archive

Vision

TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O

PHARMACEUTICAL AND BIOLOGICAL SCIENCE

EDITOR: Soumya BhattacharyaGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND

TECHNOLOGY

GNIPST Photo Gallery

For your comments/contributionORFor Back-Issues,

mailto:[email protected]
https://plus.google.com/u/0/photos/111714720327580099858/albums/5929381824307054929?authkey=CM7_k7GZrZLXngEmailto:[email protected]:[email protected]:[email protected]://plus.google.com/u/0/photos/111714720327580099858/albums/5929381824307054929?authkey=CM7_k7GZrZLXngE


2/17

MESSAGE FROM GNIPSTGNIPST BULLETIN is the official publication of Guru Nanak

Institute of Pharmaceutical Science & Technology. All the members

of GNIPST are proud to publish the 29th Volume of GNIPSTBULLETIN. Over the last two years this bulletin updating readers

with different scientific, cultural or sports activities of this

prestigious institute and promoting knowledge of recent development

in Pharmaceutical and Biological Sciences. Students section is

informing readers about some curious facts of drug discovery, science,

sports and other relevant fields. We look forward to seeing your

submission and welcome comments and ideas you may have.

LETTER TO THE EDITOR.

NEWS UPDATE

Nano-Dissectiontechninque for kidney disease

(4th

October, 2013)

A new method developed by researchers at Princeton University and

the University of Michigan called "in silico nano-dissection" uses

computers rather than scalpels to separate and identify genes from

specific cell types, enabling the systematic study of genes involved in

diseases. The team used the new method to successfully identify genes

expressed in cells known as podocytes the "work-horses" of the

kidney that malfunction in kidney disease.Read more

1
http://www.sciencedaily.com/releases/2013/10/131004154808.htmhttp://www.sciencedaily.com/releases/2013/10/131004154808.htmhttp://www.sciencedaily.com/releases/2013/10/131004154808.htmhttp://www.sciencedaily.com/releases/2013/10/131004154808.htm


3/17

Norovirus vaccine reduces symptoms of illness by

more than half (4thOctober, 2013)

An investigational vaccine appears generally well tolerated andeffective against the most common strain of norovirus, reducing themain symptoms of the gastrointestinal (GI) infection, vomiting and/or

diarrhea, by 52 percent, suggests a research.Read more

High-Dose Statins Reduce Gum Inflammation in

Heart Disease Patients(3 rd October, 2013)

Statins, commonly prescribed medications for lowering cholesterol,also reduced inflammation associated with gum disease in a new

study published in the Journal of the American College of Cardiology. The

study suggests that steps taken to reduce gum disease may also

reduce inflammation in the arteries and vice versa.Read more

Anti-Cancer drug benefits women with breast

cancer who have failed previous treatments (27thSeptember, 2013)

First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before thedisease worsens in women with advanced HER2 positive breastcancer whose cancer has recurred or progressed despite previous

treatments, including trastuzumab and lapatinib.Read more

Prostacyclin Analogs and PDE 5 Inhibitors

synergistically stimulate ATP release from human

RBCs (20th September, 2013)

2
http://www.sciencedaily.com/releases/2013/10/131004125012.htmhttp://www.sciencedaily.com/releases/2013/10/131004125012.htmhttp://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130927183142.htmhttp://www.sciencedaily.com/releases/2013/09/130927183142.htmhttp://www.sciencedaily.com/releases/2013/09/130927183142.htmhttp://www.sciencedaily.com/releases/2013/09/130927183142.htmhttp://www.sciencedaily.com/releases/2013/10/131002185652.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/10/131004125012.htm


4/17

Researchers at Saint Louis University School of Medicine have

discovered a novel interaction between prostacyclin (PGI2) analogs

and phosphodiesterase 5 (PDE5) inhibitors, two groups of drugs used

in the treatment of pulmonary arterial hypertension (PAH). They

found that, in combination, these drugs stimulate enhanced release of

a potent vasodilator adenosine triphosphate (ATP) from human red

blood cells (RBCs).Read more

Proteins identified that may help brain tumors

spread (20th September, 2013)

Scientists at the University of Alabama at Birmingham have identifieda molecular pathway that seems to contribute to the ability of

malignant glioma cells in a brain tumor to spread and invade

previously healthy brain tissue.Read more

Digoxin use associated with higher risk of death

for heart failure patients (20th September,2013)

Digoxin, a drug commonly used to treat heart conditions, wasassociated with a 72 percent higher rate of death among adults withnewly diagnosed systolic heart failure, according to a KaiserPermanente study that appears in the current online issue ofCirculation. These findings suggest that the use of digoxin should bereevaluated for the treatment of systolic heart failure in contemporary

clinical practice.Read more

Imaging technique detects pediatric liver disease

without needle biopsy (20thSeptember, 2013)

A new, non-invasive imaging technique, magnetic resonanceelastography (MRE), can now help physicians accurately detect

3
http://www.sciencedaily.com/releases/2013/09/130920143730.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920143730.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920143730.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920111246.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920111246.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920111246.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920102111.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920102111.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920102111.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920102111.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920111246.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920143730.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


5/17

fibrosis (scarring) in children with chronic liver disease, a growing

problem due in part to increasing obesity rates.Read more

Blood 'Marker' may predict diabetes risk in older

women(20thSeptember, 2013)

Older women's age and lifestyle habits may be associated with levels

of a protein possibly linked with type 2 diabetes risk, researchers say.

There is growing evidence that relatively low levels of the protein

called sex hormone binding globulin (SHBG) can indicate an

increased risk of type 2 diabetes years in advance.Read more

FDA finalizes new system to identify medical

devices(20thSeptember, 2013)

U.S. Food and Drug Administration announced a final rule for the

unique device identification system (UDI) that, once implemented,

will provide a consistent way to identify medical devices. The UDI

system has the potential to improve the quality of information in

medical device adverse events reports, which will help the FDA

identify product problems more quickly, better target recalls, and

improve patient safety. The FDA has worked closely with industry,

the clinical community and patient and consumer groups in the

development of this rule.Read more

4
http://www.sciencedaily.com/releases/2013/09/130920094746.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920094746.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/09/130920094746.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.drugs.com/news/blood-marker-may-predict-diabetes-risk-older-women-47589.htmlhttp://www.drugs.com/news/blood-marker-may-predict-diabetes-risk-older-women-47589.htmlhttp://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/EconomicAnalyses/UCM368961.pdfhttp://www.drugs.com/news/blood-marker-may-predict-diabetes-risk-older-women-47589.htmlhttp://www.drugs.com/news/blood-marker-may-predict-diabetes-risk-older-women-47589.htmlhttp://www.drugs.com/news/blood-marker-may-predict-diabetes-risk-older-women-47589.htmlhttp://www.drugs.com/news/blood-marker-may-predict-diabetes-risk-older-women-47589.htmlhttp://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/EconomicAnalyses/UCM368961.pdfhttp://www.drugs.com/news/blood-marker-may-predict-diabetes-risk-older-women-47589.htmlhttp://www.sciencedaily.com/releases/2013/09/130920094746.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


6/17

HEALTH AWARENESS

Rabies-a neglected diseaseOn 28th September World Rabies Day was observed globally.

Although prevalence and death due to this disease is really significant,Rabies is still a less concerned disease. Rabies is a zoonotic disease (adisease that is transmitted to humans from animals) that is caused bya virus. The disease affects domestic and wild animals, and is spreadto people through close contact with infectious material, usuallysaliva, via bites or scratches.

Rabies is present on all continents with the exception ofAntartica, but more than 95% of human deaths occur in Asia andAfrica. Once symptoms of the disease develop, rabies is nearly alwaysfatal.

Rabies is a neglected disease of poor and vulnerable populationswhose deaths are rarely reported. It occurs mainly in remote ruralcommunities where measures to prevent dog to human transmissionhave not been implemented. Under-reporting of rabies also preventsmobilization of resources from the international community for theelimination of human dog-mediated rabies.

Symptoms

The incubation period for rabies is typically 13 months, but may varyfrom 1 year. The initial symptoms of rabies are fever andoften pain or an unusual or unexplained tingling, pricking or burningsensation (paraesthesia) at the wound site.

As the virus spreads through the central nervous system, progressive,fatal inflammation of the brain and spinal cord develops.

5


7/17

Two forms of the disease can follow. People with furious rabiesexhibit signs of hyperactivity, excited behaviour, hydrophobia andsometimes aerophobia. After a few days, death occurs by cardio-respiratory arrest.

Paralytic rabies accounts for about 30% of the total number of humancases. This form of rabies runs a less dramatic and usually longercourse than the furious form. The muscles gradually becomeparalyzed, starting at the site of the bite or scratch. A coma slowlydevelops, and eventually death occurs. The paralytic form of rabies isoften misdiagnosed, contributing to the under-reporting of thedisease.

Diagnosis

No tests are available to diagnose rabies infection in humans beforethe onset of clinical disease, and unless the rabies-specific signs ofhydrophobia or aerophobia are present, the clinical diagnosis may bedifficult. Human rabies can be confirmed intra-vitam and postmortem by various diagnostic techniques aimed at detecting wholevirus, viral antigens or nucleic acids in infected tissues (brain, skin,

urine or saliva).Transmission

People are usually infected following a deep bite or scratch by aninfected animal. Dogs are the main host and transmitter of rabies.They are the source of infection in all of the estimated 50 000 humanrabies deaths annually in Asia and Africa.

Bats are the source of most human rabies deaths in the Americas. Batrabies has also recently emerged as a public health threat in Australiaand western Europe. Human deaths following exposure to foxes,raccoons, skunks, jackals, mongooses and other wild carnivore hostspecies are very rare.

6


8/17

Transmission can also occur when infectious material usually saliva comes into direct contact with human mucosa or fresh skinwounds. Human-to-human transmission by bite is theoreticallypossible but has never been confirmed.

Rarely, rabies may be contracted by inhalation of virus-containingaerosol or via transplantation of an infected organ. Ingestion of rawmeat or other tissues from animals infected with rabies is not a sourceof human infection.

Post-exposure prophylaxis (PEP)

Post-exposure prophylaxis (PEP) consists of:

local treatment of the wound, initiated as soon as possible afterexposure;

a course of potent and effective rabies vaccine that meets WHOrecommendations; and

the administration of rabies immunoglobulin, if indicated.

Effective treatment soon after exposure to rabies can prevent theonset of symptoms and death.

Local treatment of the wound

Removing the rabies virus at the site of the infection by chemical orphysical means is an effective means of protection. Therefore, promptlocal treatment of all bite wounds and scratches that may becontaminated with rabies virus is important. Recommended first-aidprocedures include immediate and thorough flushing and washing ofthe wound for a minimum of 15 minutes with soap and water,

detergent, povidone iodine or other substances that kill the rabiesvirus.

7


9/17

Post Exposure Prophylaxis

Categories of contact withsuspect rabid animal

Post-exposure prophylaxismeasures

Category I touching orfeeding animals, licks on intactskin

None

Category II nibbling ofuncovered skin, minorscratches or abrasions withoutbleeding

Immediate vaccination andlocal treatment of the wound

Category III single or

multiple transdermal bites orscratches, licks on broken skin;contamination of mucousmembrane with saliva fromlicks, contacts with bats.

Immediate vaccination and

administration of rabiesimmunoglobulin; localtreatment of the wound

All category II and III exposures assessed as carrying a risk ofdeveloping rabies require PEP. This risk is increased if:

the biting mammal is a known rabies reservoir or vector species; the animal looks sick or has an abnormal behaviour; a wound or mucous membrane was contaminated by the animals

saliva; the bite was unprovoked; and the animal has not been vaccinated.

In developing countries, the vaccination status of the suspectedanimal alone should not be considered when deciding whether to

initiate prophylaxis or not.

Prevention

Eliminating rabies in dogs

8


10/17

Rabies is a vaccine-preventable disease. The most cost-effectivestrategy for preventing rabies in people is by eliminating rabies indogs through vaccination. Vaccination of animals (mostly dogs) hasreduced the number of human (and animal) rabies cases in several

countries, particularly in Latin America. However, recent increases inhuman rabies deaths in parts of Africa, Asia and Latin Americasuggest that rabies is re-emerging as a serious public health issue.

Preventing human rabies through control of domestic dog rabies is arealistic goal for large parts of Africa and Asia, and is justifiedfinancially by the future savings of discontinuing post-exposureprophylaxis for people.

Preventive immunization in people

Safe, effective vaccines can be used for pre-exposure immunization.This is recommended for travellers spending a lot of time outdoors,especially in rural areas, involved in activities such as bicycling,camping, or hiking as well as for long-term travellers and expatriatesliving in areas with a significant risk of exposure. Pre-exposureimmunization is also recommended for people in certain high-risk

occupations such as laboratory workers dealing with live rabies virusand other rabies-related viruses (lyssaviruses), and people involved inany activities that might bring them professionally or otherwise intodirect contact with bats, carnivores, and other mammals in rabies-affected areas.

(Based on WHO factsheet)

9


11/17

DISEASE OUTBREAK NEWS

Middle East respiratory syndrome coronavirus

(MERS-CoV) (20th September,2013)Two patients earlier reported as laboratory-confirmed with Middle

East respiratory syndrome coronavirus (MERS-CoV) infection in

Italy in the Disease Outbreak News on 2 June 2013 are being

reclassified as probable cases.Read more

FORTHCOMING EVENTS

GNIPST will organize pre puja celebration programme, Saaranyaon 7th October, 2013 in college Auditorium.

GNIPST Intra college football tournament will be held on 7th -9th

October,2013The 2nd Pharm. Tech IAPST International Conference on "New insights into

diseases and recent therapeutic approaches" from 17th to 19th January 2014 in

Kolkata, India.Read more

DRUGS UPDATES

FDA approval expands access to artificial heart

valve for inoperable patients(23th September, 2013)

10
http://www.who.int/csr/don/2013_09_20/en/index.htmlhttp://www.who.int/csr/don/2013_09_20/en/index.htmlhttp://www.who.int/csr/don/2013_09_20/en/index.htmlhttp://www.iapst.com/http://www.iapst.com/http://www.iapst.com/http://www.iapst.com/http://www.who.int/csr/don/2013_09_20/en/index.html


12/17

The U.S. Food and Drug Administration approved revised labeling for

the Sapien Transcatheter Heart Valve (THV), making the device

available to an expanded group of patients who have inoperable aortic

valve stenosis, a disease of the heart valves that causes narrowing of

the aortic valve, restricting blood flow from the heart.Read more

FDA approves Abraxane for late-stage pancreatic

cancer(6th September, 2013)

The U.S. Food and Drug Administration today expanded theapproved uses of Abraxane (paclitaxel protein-bound particles forinjectable suspension, albumin-bound) to treat patients with late-

stage (metastatic) pancreatic cancer.Read more

CAMPUS NEWS

GNIPST organized a garment distribution programme

on 28th September, 2013 at Dakshineswar Kali Temple and

Adyapith, Kolkata. On this remarkable event about hundredpeople have received garments. More than hundred

students and most of the faculties participated on that day

with lot of enthusiasm.

GNIPST celebrated World Heart Day(29th September) andPharmacists Day(25th September)on 25thand26th September,

2013 in GNIPST Auditorium. A seminar on Violence againstwoman and female foeticide was held on GNIPST Auditorium on

25th September organized by JABALA Action Research

Organization. On 26th September an intra-college Oral and Poster

presentation competition related to World Pharmacists day and

11
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm367442.htm


13/17

Heart day was held in GNIPST. Ms. Purbali Chakraborty of

B.Pharm 4th year won the first prize in Oral Presentation. The

winner of Poster presentation was the group ofMs. Utsa Sen, Mr.

Koushik Saha and Niladri Banerjee (B.Pharm 4

th

year). A goodnumber of students have participated in both the competition

with their valuable views.

Teachers day was celebrated on 5th September, 2013 by

the students of GNIPST in GNIPST Auditorium.

Azalea (exotic flower ) , the fresher welcome programme fornewcomers of GNIPST in the session 2013-14 was held on 8th

August in GNIPST Auditorium.

One day seminar cum teachers development programme forschool teachers on the theme ofRecent Trends of Life Sciences

in Higher Education organized by GNIPST held on 29th June,

2013 at GNIPST auditorium. The programme was inaugurated by

Prof . Asit Guha, Director of JIS Group, Mr. U.S. Mukherjee, Dy

Director of JIS Group and Dr. Abhijit Sengupta, Director cum

Principal of GNIPST with lamp lighting. The programme started

with an opening song performed by the B.Pharm students of this

institute. The seminar consists of a series of lectures, video

presentations and poster session. On the pre lunch session 4

lectures were given by Dr. Lopamudra Dutta, Mr. Debabrata

Ghosh Dastidar, Ms. Swati Nandy and Ms. Tamalika Chakraborty

respectively. On their presentation the speakers enlighten therecent development of Pharmacy, Genetics and Microbiology and

their correlation with Life Sciences. On the post lunch session, Ms.

Saini Setua and Ms. Sanchari Bhattacharjee explained the recent

development and career opportunities in Biotechnology and

12


14/17

Hospital Management. The programme was concluded with

valedictory session and certificate distribution.

About 50 Higher secondary school teachers from different

schools of Kolkata and North& South 24 Parganas district of

West Bengal participated in this programme. A good interactive

session between participants and speakers was observed in the

seminar. The seminar was a great success with the effort of

faculties, staffs and students of our Institute. It was a unique

discussion platform for school teachers and professional of the

emerging and newer branches of Life Science.

STUDENTS SECTION

WHO CAN ANSWER FIRST????

Name of which disease was derived from Latin

word for madness?

Which famous scientists death anniversary isobserved as World Rabies Day?

Answer of Previous Issues Questions:A) Charles Dotter B)ECG

Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for StudentsSection& answers of this Section [email protected]

13


15/17

EDITORS NOTE

I am proud to publish the 3rd

issue of 29th

Volume of GNIPST

BULLETIN. GNIPST BULLETIN now connected globally through

facebook account GNIPST bulletinI want to convey my thanks to all the GNIPST members and the

readers for their valuable comments, encouragement and supports.

I am thankful to Dr. Abhijit Sengupta, Director of GNIPST for his

valuable advice and encouragement. Special thanks to Dr. Prerona

Saha andMr. Debabrata Ghosh Dastidar for their kind co-operation

and technical supports.

An important part of the improvement of the bulletin is thecontribution of the readers. You are invited to send in your write ups,

notes, critiques or any kind of contribution for the forthcoming special

and regular issue.

GNIPST BULLETIN wishes all the readers a happy Autumn

Festival.

ARCHIVE

The following B.Pharm. final year students have qualified,

GPAT-2013. We congratulate them all.

AAAmmmaaannnppprrreeeeeetttKKKaaauuurrr,,, MMMooohhhuuuaaa DDDaaasss,,,

SSSooouuurrraaavvvBBBaaagggccchhhiii,,,UUUddddddiiippptttaaaGGGhhhooossshhh DDDaaassstttiiidddaaarrr,,,

SSSiiiddddddaaarrrttthhh SSShhhaaahhh,,, PPPrrraaappptttiiiCCChhhaaakkkrrraaabbbooorrrtttyyy,,,

SSSuuubbbhhhrrraaadddiiipppRRRoooyyyccchhhooouuudddhhhuuurrryyy,,, SSSooouuummmyyyaaajjjiiittt DDDaaasss,,,

14


16/17

MMMooouuunnnooommmuuukkkhhhaaarrrBBBhhhaaattttttaaaccchhhaaarrrjjjeeeeee...

GGGNNNIIIPPPSSSTTT iiisss nnnooowww aaapppppprrrooovvveeeddd bbbyyy AAAIIICCCTTTEEE aaannnddd aaaffffffiiillliiiaaattteeeddd tttooo

WWWBBBUUUTTTfffooorrr cccooonnnddduuuccctttiiinnnggg ttthhheee tttwwwooo yyyeeeaaarrrsss pppooosssttt gggrrraaaddduuuaaattteee cccooouuurrrssseee

(((MMM...PPPhhhaaarrrmmm))) iiinnn PPPHHHAAARRRMMMAAACCCEEEUUUTTTIIICCCSSS... TTThhheeeaaapppppprrrooovvveeedddnnnuuummmbbbeeerrr

ooofffssseeeaaattt iiisss111888...

The general body meeting of APTI, Bengal Branch has been conducted

at GNIPST on 15th June, 2012. The program started with a nice

presentation by Dr. Pulok Kr. Mukherjee, School of Natural Products,

JU on the skill to write a good manuscript for publication in impact

journals. It was followed by nearly two hour long discussion among

more than thirty participants on different aspects of pharmacy

education. Five nonmember participants applied for membership on

that very day.

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm) in

P H A R M A C O L O G Y . The approved number of seat is 18.The number of seats in B.Pharm. has been increased from 60 to 120.

AICTE has sanctioned a release of grant under Research Promotion

Scheme (RPS) during the financial year 2012-13to GNIPST as per the

details below:

a. Beneficiary Institution: Guru Nanak Institution of PharmaceuticalScience & Technology.

b.Principal Investigator: Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d.Approved duration: 3 years

15


17/17

e. Title of the project: Screening and identification of potential

medicinal plant ofPurulia & Bankura districts of West Bengal with

respect to diseases such as diabetes, rheumatism, Jaundice,

hypertension and developing biotechnological tools for enhancingbioactive molecules in these plants.

gnipst bulletin 29.3

Documents